BIRADS 3 TUMORS ON THE ULTRASOUND: ONCOLOGICAL RISKS

Abstract

Introduction. BIRADS 3 tumors are an area of interest for the oncologist and the gynecologist considering likelihood of cancer less than or equal to 2%.Aim. To analyze the frequency of diagnoses in BIRADS 3 of ultrasound, to determine the risk of breast cancer in women with BIRADS 3 after the first ultrasound.Materials and methods. A prospective study was carried out, the participants of were women from the TransBaikal Regional Oncology Center with BIRADS 3 after the first ultrasound.expert-class ultrasound examination of the breast was carried out for all patients using a General Electric Voluson E6 device (Austria, 2011).The fine-needle aspiration biopsy (FNA) with cytological examination, core tumor biopsy (Biopsy needle, Italy, 14 G / 2.00 mm) with histological examination were performed according to indications.Statistical analysis was carried out using the IBM SPSS Statistics Version 25.0 program"Results. Almost every third of the woman referred to an oncologist does not have a BIRADS gradation in the ultrasound report. Changing the BIRADS category was performed in 22.4% of cases after expert ultrasound Biopsy of tumors with the BIRADS 3 was performed in 31% cases, among them breast cancer was detected in 3,4% of cases, intraductal papilloma with atypia – 1,7%.Conclusion. The use of BIRADS grading is necessary for the breast ultrasound, which affects the routing and examination. The management for patients with BIRADS 3 ultrasound should be individualized, considering clinical, radiological features.